Results Local disruption of Gs signaling in the dorsal vagal complex impairs energy balance and semaglutide-induced weight loss To test whether semaglutide recruits the Gs pathway in hindbrain neurons to drive weight loss, we delivered a virus encoding Cre recombinase and a red fluorescent protein (AAV1-hsyn-cre-P2A-tdTomato) to the dorsal vagal complex (DVC) of Gnas conditional knockout mice 29 (Gnas fl/fl ) to selectively knockout the gene encoding the Gs protein (Fig
It creates a cellular environment that is hostile to the very goals of the peptide therapy
It contains BPC-157 (10mg), a 15-amino-acid synthetic peptide derived from a sequence found in human gastric juice protein
It is FDA-approved to treat both type 2 diabetes and, more recently, obesity
Possible side effects include: Mild stomach discomfort Nausea Bloating Indigestion Headache Allergic reactions in sensitive individuals Seek immediate medical attention if you experience swelling of the face, lips, tongue, difficulty breathing, or signs of a severe allergic reaction